<p><strong>Healius Limited</strong> (ASX:HLS) 的股东应该对过去一个月股价上涨 23% 感到高兴。但不要羡慕持有者——回顾过去五年，回报实在糟糕。在此期间，股价下跌了 73%，让人失望。因此，我们对短期的上涨持谨慎态度。然而，在最好的情况下（远非 <em>既成事实</em>），这种改善的表现可能会持续。</p>
<p>更令人鼓舞的是，公司在过去 7 天内增加了 8700 万澳元的市值，因此让我们看看能否找出导致股东在过去五年中亏损的原因。</p>
<p>我们发现 21 只美国股票预计明年将支付超过 6% 的股息收益率。请查看完整名单，免费获取。</p>
<p>由于 Healius 在过去 12 个月中出现亏损，我们认为市场可能更关注收入和收入增长，至少目前是这样。一般来说，没有利润的公司预计每年都要增长收入，并且增长速度要快。可以想象，快速的收入增长在维持时，通常会导致快速的利润增长。</p>
<p>在过去五年中，Healius 的收入每年缩减 3.9%。这并不是投资者通常想看到的。如果一家公司亏损，你希望它能够增长，因此股价在此期间每年下跌 12% 也就不足为奇。购买一家亏损且不增长收入的公司的股票需要一定的心理韧性（或鲁莽）。这并不是我们所知的成功投资者所追求的目标。</p>
<p>您可以在下面看到收益和收入随时间的变化（点击图片可以发现确切的数值）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908"/></p>
<p>ASX:HLS 收益和收入增长 2025 年 11 月 26 日</p>
<p>值得注意的是，我们在过去一个季度看到显著的内部人士买入，这被我们视为积极信号。另一方面，我们认为收入和收益趋势是衡量业务更有意义的指标。因此，查看分析师对 Healius 未来收益的看法（免费的利润预测）是非常有意义的。</p>
<h2>总股东回报（TSR）如何？</h2>
<p>我们不能不提 Healius 的 <em>总股东回报</em>（TSR）与其 <em>股价回报</em> 之间的差异。TSR 是一种回报计算，考虑了现金股息的价值（假设收到的任何股息都被再投资）以及任何折扣融资和分拆的计算价值。由于其股息支付的历史，Healius 的 TSR 在过去五年中下降了 57%，但并没有股价回报那么糟糕。</p>
<h2>不同的视角</h2>
<p>虽然整体市场在过去一年中上涨了约 5.8%，但 Healius 的股东却损失了 2.7%。然而，请记住，即使是最好的股票，有时在十二个月内也会表现不佳。不幸的是，长期股东的损失更为严重，过去五年中损失了 9%。在认为股价会稳定之前，我们希望有明确的信息表明公司将会增长。内部人士买入股票固然好，但我们建议您查看内部人士的买入价格。</p>
<p>还有很多其他公司也有内部人士买入股票。您可能不想错过这份 <strong>免费的</strong> 被低估的小型公司的名单，内部人士正在买入。</p>
<p><em>请注意，本文中引用的市场回报反映了当前在澳大利亚交易所交易的股票的市场加权平均回报。</em></p>

<p>Healius Limited（ASX:HLS）股票在过去一周上涨了 14%，在过去一个月上涨了 23%，但在五年内下跌了 73%。尽管公司在最近增加了 8700 万澳元的市值，但五年来年收入缩减了 3.9%。有内部人士买入的情况被注意到，但长期股东面临 57% 的总回报率下降。市场去年上涨了 5.8%，而 Healius 的股东则损失了 2.7%</p>

<p><strong>Healius Limited</strong> (ASX:HLS) shareholders should be happy to see the share price up 23% in the last month. But don't envy holders -- looking back over 5 years the returns have been really bad. The share price has failed to impress anyone , down a sizable 73% during that time. So we're hesitant to put much weight behind the short term increase. However, in the best case scenario (far from <em>fait accompli</em>), this improved performance might be sustained.</p>
<div class="lb-trans"><p><strong>Healius Limited</strong> (ASX:HLS) 的股东应该对过去一个月股价上涨 23% 感到高兴。但不要羡慕持有者——回顾过去五年，回报实在糟糕。在此期间，股价下跌了 73%，让人失望。因此，我们对短期的上涨持谨慎态度。然而，在最好的情况下（远非 <em>既成事实</em>），这种改善的表现可能会持续。</p>
</div><p>On a more encouraging note the company has added AU$87m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.</p>
<div class="lb-trans"><p>更令人鼓舞的是，公司在过去 7 天内增加了 8700 万澳元的市值，因此让我们看看能否找出导致股东在过去五年中亏损的原因。</p>
</div><p>We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.</p>
<div class="lb-trans"><p>我们发现 21 只美国股票预计明年将支付超过 6% 的股息收益率。请查看完整名单，免费获取。</p>
</div><p>Because Healius made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.</p>
<div class="lb-trans"><p>由于 Healius 在过去 12 个月中出现亏损，我们认为市场可能更关注收入和收入增长，至少目前是这样。一般来说，没有利润的公司预计每年都要增长收入，并且增长速度要快。可以想象，快速的收入增长在维持时，通常会导致快速的利润增长。</p>
</div><p>In the last five years Healius saw its revenue shrink by 3.9% per year. That's not what investors generally want to see. If a business loses money, you want it to grow, so no surprises that the share price has dropped 12% each year in that time. It takes a certain kind of mental fortitude (or recklessness) to buy shares in a company that loses money and doesn't grow revenue. That is not really what the successful investors we know aim for.</p>
<div class="lb-trans"><p>在过去五年中，Healius 的收入每年缩减 3.9%。这并不是投资者通常想看到的。如果一家公司亏损，你希望它能够增长，因此股价在此期间每年下跌 12% 也就不足为奇。购买一家亏损且不增长收入的公司的股票需要一定的心理韧性（或鲁莽）。这并不是我们所知的成功投资者所追求的目标。</p>
</div><p>You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).</p>
<div class="lb-trans"><p>您可以在下面看到收益和收入随时间的变化（点击图片可以发现确切的数值）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908" alt="" original-src="https://images.simplywall.st/asset/chart/419262-earnings-and-revenue-growth-1-dark-2/1764190505908"/></p>
<p>ASX:HLS Earnings and Revenue Growth November 26th 2025</p>
<div class="lb-trans"><p>ASX:HLS 收益和收入增长 2025 年 11 月 26 日</p>
</div><p>It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. So it makes a lot of sense to check out what analysts think Healius will earn in the future (free profit forecasts).</p>
<div class="lb-trans"><p>值得注意的是，我们在过去一个季度看到显著的内部人士买入，这被我们视为积极信号。另一方面，我们认为收入和收益趋势是衡量业务更有意义的指标。因此，查看分析师对 Healius 未来收益的看法（免费的利润预测）是非常有意义的。</p>
</div><h2>What About The Total Shareholder Return (TSR)?</h2>
<div class="lb-trans"><h2>总股东回报（TSR）如何？</h2>
</div><p>We'd be remiss not to mention the difference between Healius' <em>total shareholder return</em> (TSR) and its <em>share price return</em>. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Its history of dividend payouts mean that Healius' TSR, which was a 57% <em>drop</em> over the last 5 years, was not as bad as the share price return.</p>
<div class="lb-trans"><p>我们不能不提 Healius 的 <em>总股东回报</em>（TSR）与其 <em>股价回报</em> 之间的差异。TSR 是一种回报计算，考虑了现金股息的价值（假设收到的任何股息都被再投资）以及任何折扣融资和分拆的计算价值。由于其股息支付的历史，Healius 的 TSR 在过去五年中下降了 57%，但并没有股价回报那么糟糕。</p>
</div><h2>A Different Perspective</h2>
<div class="lb-trans"><h2>不同的视角</h2>
</div><p>While the broader market gained around 5.8% in the last year, Healius shareholders lost 2.7%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, longer term shareholders are suffering worse, given the loss of 9% doled out over the last five years. We would want clear information suggesting the company will grow, before taking the view that the share price will stabilize. It is all well and good that insiders have been buying shares, but we suggest you check here to see what price insiders were buying at.</p>
<div class="lb-trans"><p>虽然整体市场在过去一年中上涨了约 5.8%，但 Healius 的股东却损失了 2.7%。然而，请记住，即使是最好的股票，有时在十二个月内也会表现不佳。不幸的是，长期股东的损失更为严重，过去五年中损失了 9%。在认为股价会稳定之前，我们希望有明确的信息表明公司将会增长。内部人士买入股票固然好，但我们建议您查看内部人士的买入价格。</p>
</div><p>There are plenty of other companies that have insiders buying up shares. You probably do <strong>not</strong> want to miss this <strong>free</strong> list of undervalued small cap companies that insiders are buying.</p>
<div class="lb-trans"><p>还有很多其他公司也有内部人士买入股票。您可能不想错过这份 <strong>免费的</strong> 被低估的小型公司的名单，内部人士正在买入。</p>
</div><p><em>Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges.</em></p>
<div class="lb-trans"><p><em>请注意，本文中引用的市场回报反映了当前在澳大利亚交易所交易的股票的市场加权平均回报。</em></p>
</div>

Healius（ASX:HLS）的股东在过去一周内股价上涨了 14%，但在过去五年中仍然亏损